Use of adrenergic bronchodilators by pediatric allergists and pulmonologists

R W Newcomb1

  • 1Pediatric Allergy and Pulmonology Service, Merrillville, IN 46410.

Insights

Pediatricians commonly use inhaled adrenergic bronchodilators for children with respiratory conditions across various settings. Expert practice shows flexibility in dosing, with inhaled albuterol, metaproterenol, or terbutaline sulfate being preferred choices.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology

Background:

  • Adrenergic bronchodilators are crucial for managing pediatric respiratory conditions.
  • Understanding expert physician practices is key to optimizing treatment guidelines.

Purpose of the Study:

  • To investigate current pediatric specialist practices regarding adrenergic bronchodilator use in children.
  • To identify preferred agents, settings, and dosing strategies for pediatric bronchodilator therapy.

Main Methods:

  • Survey of 21 pediatricians specializing in allergy, pulmonology, or both.
  • Inquiry into the use of adrenergic bronchodilators across different age groups and clinical settings (home, ED, hospital).

Main Results:

  • Most pediatricians utilize inhaled bronchodilators for all ages and settings.
  • Inhaled albuterol, metaproterenol, and terbutaline sulfate are frequently preferred.
  • Dosing intervals are adjusted based on clinical setting, with shorter intervals common in emergency and hospital care.
  • Significant variation exists in the use of specific agents and intravenous administration.

Conclusions:

  • Expert pediatricians demonstrate varied but generally consistent approaches to adrenergic bronchodilator therapy.
  • Inhaled medications are favored across settings and ages, with flexible dosing.
  • Further standardization may improve outcomes for pediatric asthma, bronchopulmonary dysplasia, and bronchiolitis.

Related Concept Videos

Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Classification01:18

Adrenergic Agonists: Therapeutic Classification

Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...